Floatz logo

Ide-Cel

Colorectal Cancer

Dispatch BiotherapeuticsCell therapyPhase 1Active
C
36/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
59/ 100

Competitive context

481 Active assets in the Colorectal Cancer cohort.

Asset / SponsorPhaseRating
Calcium folinate pentahydrate
UNICANCER
Phase 4BB
PANITUMUMAB
MSPU des 3 Provinces
Phase 3BB
Levoleucovorin
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3BB
FLUOROURACILUM
UNICANCER
Phase 4BB
Eloxatin
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 4BB

View all 50 →

Same molecule, other indications

Ide-Cel is also rated in:

Gastric AdenocarcinomaDormant
C
Indicative ·
39 / 100
View asset →
Esophageal AdenocarcinomaDormant
C
Indicative ·
39 / 100
View asset →
Gastroesophageal AdenocarcinomaDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →